CG Oncology Ownership | Who Owns CG Oncology?
CG Oncology Ownership Summary
CG Oncology is owned by 99.57% institutional investors, 1.17% insiders. Decheng capital is the largest institutional shareholder, holding 8.36% of CGON shares.
CGON Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | CG Oncology | 99.57% | 1.17% | -0.74% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Decheng capital | 6.37M | 8.36% | $165.66M |
| Blackrock funding, inc. /de | 4.46M | 5.85% | $115.87M |
| Tcg crossover management | 3.67M | 4.81% | $95.43M |
| Braidwell lp | 3.28M | 4.31% | $85.37M |
| Kynam capital management, lp | 2.46M | 3.22% | $63.90M |
| Foresite capital management vi | 2.22M | 2.91% | $57.76M |
| Orbimed advisors | 1.88M | 2.46% | $48.82M |
| Rtw investments, lp | 1.70M | 2.23% | $44.23M |
| Avidity partners management lp | 1.50M | 1.97% | $39.00M |
| Point72 asset management | 1.48M | 1.94% | $38.36M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Decheng capital | 6.37M | 41.84% | $165.66M |
| Foresite capital management vi | 2.22M | 32.47% | $57.76M |
| Foresite capital management v | 1.00M | 32.34% | $26.11M |
| Tcg crossover management | 3.67M | 10.90% | $95.43M |
| Avidity partners management lp | 1.50M | 7.77% | $39.00M |
| Kynam capital management, lp | 2.46M | 6.88% | $63.90M |
| Saturn v capital management | 586.65K | 6.18% | $15.25M |
| Braidwell lp | 3.28M | 2.92% | $85.37M |
| Silverarc capital management | 541.03K | 2.59% | $14.07M |
| Adar1 capital management | 523.22K | 2.09% | $13.60M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Candriam s.c.a. | 763.58K | 0.11% | 763.58K |
| Pictet asset management sa | 1.35M | 0.04% | 606.55K |
| Mangrove partners | 555.12K | 1.55% | 555.12K |
| Silverarc capital management | 541.03K | 2.59% | 541.03K |
| Avidity partners management lp | 1.50M | 7.77% | 519.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Marshall wace, llp | - | - | -2.42M |
| Deerfield management company, l.p. (series c) | - | - | -850.70K |
| Avoro capital advisors | - | - | -700.00K |
| Orbimed advisors | 1.88M | 1.22% | -594.14K |
| Abg-wtt global life science capital partners gp | - | - | -495.53K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Candriam s.c.a. | 763.58K | 0.11% | 763.58K | $19.85M |
| Mangrove partners | 555.12K | 1.55% | 555.12K | $14.43M |
| Silverarc capital management | 541.03K | 2.59% | 541.03K | $14.07M |
| Ikarian capital | 155.00K | 0.77% | 155.00K | $4.03M |
| Tang capital management | 87.50K | 0.12% | 87.50K | $2.27M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Advisornet financial | -2.00 |
| Parallel advisors | -3.00 |
| Quantbot technologies lp | -7.00 |
| Stephens consulting | -15.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 167 | 16.78% | 75,899,259 | 8.77% | 99 | 1.19% | 116 | 31.82% | 28 | -15.15% |
| Mar 31, 2025 | 144 | 1.41% | 70,762,639 | 10.06% | 92 | 1.01% | 88 | -7.37% | 34 | 25.93% |
| Dec 31, 2024 | 143 | 16.26% | 66,220,894 | 26.90% | 98 | 1.63% | 96 | 10.34% | 27 | 50.00% |
| Sep 30, 2024 | 123 | 10.81% | 52,183,069 | 20.58% | 77 | 1.84% | 87 | 14.47% | 18 | - |
| Jun 30, 2024 | 111 | 14.43% | 43,276,586 | 11.62% | 64 | 0.96% | 76 | -20.83% | 18 | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 05, 2025 | Mulay James | - | Sell | $243.66K |
| Sep 05, 2025 | Mulay James | - | Sell | $103.41K |
| Sep 05, 2025 | Mulay James | - | Sell | $376.06K |
| Sep 05, 2025 | Mulay James | - | Sell | $128.66K |
| Sep 03, 2025 | Song Hong Fang | - | Sell | $1.92M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 3 |
| 2024 Q4 | - | 4 |
| 2024 Q1 | 1 | - |
CGON Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools